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The World Health Organization and collaborating agencies 
have set the goal of eliminating dog-mediated human ra-
bies by 2030. Building on experience with rabies endemic 
countries, we constructed a user-friendly tool to help public 
health officials plan the resources needed to achieve this 
goal through mass vaccination of dogs.
Globally, rabies kills ≈60,000 persons annually; most (≈99%) cases are transmitted by domestic dogs (1–3). 
Controlling dog rabies through periodic mass vaccina-
tion campaigns substantially reduces human exposures 
(4). The elimination of dog rabies in most of the Western 
Hemisphere and countries in Asia has demonstrated the 
effectiveness and sustainability of vaccinating dogs (5,6) 
by combining massive dog rabies vaccination with coor-
dinated efforts of the medical and veterinary sectors (One 
Health approach), including education about responsible 
pet ownership, rabies awareness campaigns, and access to 
postexposure prophylaxis (5,6).
The World Health Organization recommends that at 
least 70% of the dog population be vaccinated to control 
and potentially eliminate dog rabies (3). In 2016, WHO and 
partner organizations set the goal of eliminating dog-medi-
ated human rabies by 2030 (7). This goal could be achieved 
by massive, costly administration of preexposure and post-
exposure prophylaxis, mass vaccination of dogs, or both.
Countries to which rabies is endemic in dogs are at 
different stages in their rabies control efforts (5,8). Coun-
tries at early stages face barriers related to a limited under-
standing of the local epidemiology, logistic and operational 
challenges, competing priorities from other diseases, and 
lack of planning tools to reasonably project the resources 
needed. During 2016, we estimated the resources poten-
tially required to eliminate dog rabies globally by 2030 
(7). We combined multiple data sources to estimate 4 key 
factors that affect this goal: country development, cost of 
dog vaccination programs, potential demand for dog rabies 
vaccine, and estimated number of vaccinators. We aimed 
to realistically assess the global situation by highlighting 
the main challenges that might hamper elimination efforts. 
However, although these global estimates can inform an 
important discussion about global and regional strategic 
planning and resource mobilization, they are not necessar-
ily useful to inform country-level decision-making. We ad-
dressed this limitation by providing a user-friendly tool that 
requires only limited country-specific data to help countries 
plan toward the goal of eliminating dog rabies through 
mass dog vaccination.
We designed the tool to plan for dog rabies elimina-
tion by 2030 (a 13-year framework). We assumed 13 years 
would be enough time for even the least developed rabies 
control programs to achieve elimination, provided the coun-
try was fully committed. The country’s starting point within 
this time frame would depend on its current dog vaccination 
rate, and the given country would demonstrate incremental 
improvements in preparation for the vaccination campaign 
(e.g., training of workforce involved, dog population sur-
veys) or in the proportion of the dog population vaccinated. 
The tool requires input of demographic data (human popu-
lation, percentage urban, human-to-dog ratio); current dog 
vaccination coverage; logistic data for the campaigns (avail-
able vaccinators, dog vaccination rates, campaign duration); 
and an estimated cost per vaccinated dog. We constructed a 
worksheet to help users estimate the cost per vaccinated dog 
based on a pilot campaign. The tool (including assumptions, 
instructions, and data requirements) is available for public 
use (online Technical Appendix, https://wwwnc.cdc.gov/
EID/article/23/12/17-1148-Techapp1.xlsm) and already has 
been used in Haiti and Guatemala as part of a rabies elimi-
nation workshop held at the Centers for Disease Control and 
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1Prevention (Atlanta, GA, USA). Users can account for un-
certainty in point estimates by varying model parameters.
To show the utility of the planning tool, we input 
known information from 2 recent mass dog vaccination 
campaigns in western Kenya to project expected long-
term costs and a timeline for rabies elimination. With 
a conservative estimate of 523 (95% CI 138–1,100) 
annual human rabies-associated deaths and substantial 
medical costs (1), Kenya is actively trying to eliminate 
human rabies by 2030 (9). We used the following values: 
46,050,302 persons, of whom 26% live in urban areas; 
7.4 and 21.2 humans per dog in rural and urban areas, 
respectively; 5% of the dog population vaccinated; 
4,300 available vaccinators; 100 dogs vaccinated daily 
per vaccinator; a 21-day campaign in each region; an 
estimated cost per dog vaccinated of US $1.81 (range 
US $1.48–$2.12); and 0% discount rate (Figure). Con-
ditional on the availability of resources, the results sug-
gest that Kenya can eliminate dog rabies during the next 
13 years, in line with the 2030 global goal; vaccination 
campaigns would cost ≈US $62.0 million (range US 
$50.6 million–$72.8 million), equivalent to ≈$56.0 mil-
lion additional aggregate spending over 13 years (not 
discounted). If the average vaccination rate was 100 
dogs per vaccinator per day, Kenya would have enough 
capacity to conduct 21-day campaigns and reach the 
70% dog vaccination goal.
The tool enables users to estimate the resources re-
quired to eliminate rabies using country-specific input 
values. We hope this tool will help stimulate and inform a 
necessary discussion on strategic planning, resource mo-
bilization, and continuous execution of rabies elimination.
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Visceral pentastomiasis is usually found incidentally dur-
ing surgery. We describe a case of visceral pentastomiasis 
discovered during inguinoscrotal hernia surgery for a man 
from Benin, Africa. Because surgical removal of nymphs is 
needed for symptomatic patients only, this patient’s asymp-
tomatic pentastomiasis was not treated and he recovered 
from surgery uneventfully. 
In November 2015, a surgeon from Belgium, working for Medics without Vacation in Bassila, Benin, Africa, 
incidentally discovered pentastomiasis in an adult man dur-
ing surgery for a massive inguinoscrotal hernia (half a liter 
content). Other than the hernia, the patient had no health 
problems. During the procedure, the surgeon observed at 
least 10 coiled, larva-like structures on the patient’s peri-
toneal tissue. He removed the hernial sac and sent a tis-
sue specimen to the national reference laboratory for para-
sitology at the Institute of Tropical Medicine (Antwerp, 
Belgium) for identification of the parasite. Apart from the 
hernia symptoms, the patient was asymptomatic, so the 
parasites were not removed; the patient’s surgical recovery 
was uneventful.
Macroscopic examination of the peritoneal tissue 
detected 8 distinct, typical larva-like structures with an 
average length of 1–2 cm (Figure, panel A). Because the 
structures were suspected to be pentastomes, they were 
compared with reference material from the Institute of 
Tropical Medicine Educational Department (Figure, panel 
B) and confirmed as Armillifer spp. nymphs. On the basis 
of the patient’s residence in Benin, and the fact that the 
recovered nymphs consistently exhibited <22 annuli, the 
structures were presumptively identified as A. armillatus 
(1,2). Adults of this species are often found in the respira-
tory system of large snakes. Although no information was 
available regarding the patient’s contact with snakes, the 
presence of this parasite in a resident of Benin is not sur-
prising because snake consumption in that country is com-
mon practice. The patient’s surgeon confirmed that dead 
snakes were indeed often sold for consumption along the 
streets near the hospital.
The Pentastomida are a peculiar group of gonochoric, 
vermiform endoparasites, currently classified as a unique 
phylum, related to branchiuran crustaceans (3). The main 
characteristics of this group of ancient parasitic arthropods 
are an often annulated elongate body and a mouth typically 
flanked by 2 pairs of hooks. 
Human visceral pentastomiasis can be caused by sev-
eral species of pentastomes: Linguatula serrata (world-
wide, predominantly the Middle East), A. armillatus 
(West and Central Africa), A. moniliformis (Southeast 
Asia), A. grandis (Africa), A. agkistrodontis (China), Po-
rocephalus crotali (worldwide, predominantly the Ameri-
cas), and P. taiwana (China) (2,4,5). Reported cases of 
human visceral pentastomiasis were caused mainly by A. 
armillatus pentastomes (6) from infected snakes, which 
shed ova in excretions and respiratory secretions, thereby 
